SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-24-023247
Filing Date
2024-04-30
Accepted
2024-04-30 08:41:14
Documents
6
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 DEF 14A ny20026757x1_def14a.htm DEF 14A 818097
2 logo_neurobo.jpg GRAPHIC 50705
3 ny20026757x1_pvp02.jpg GRAPHIC 118239
4 ny20026757x1_pvp01x1.jpg GRAPHIC 190026
5 ny20026757x1_pc01x1.jpg GRAPHIC 525274
6 ny20026757x1_pc02x1.jpg GRAPHIC 452480
  Complete submission text file 0001140361-24-023247.txt   2658962
Mailing Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138
Business Address 545 CONCORD AVENUE SUITE 210 CAMBRIDGE MA 02138 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 24894180
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)